Orphan mitochondrial diseases as a translational segue to adult neurodegenerative disease -Guy Miller, MD, PhD -08/14/2012 - 6:00pm

Event Information
Event Topic: 
Orphan mitochondrial diseases as a translational segue to adult neurodegenerative disease
Event Date: 
08/14/2012 - 6:00pm
Event Location: 
Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA
Speaker Information
Event Speaker: 
Guy Miller, MD, PhD
Event Speaker Title: 
Chairman, CEO
Event Speaker Company: 
Edison Pharmaceuticals, Inc
Event Speaker Bio: 


Guy Miller, MD, PhD

Guy Miller, MD, PhD is Chairman and Chief Executive Officer of Edison Pharmaceuticals, Inc. Edison is focused on the development of drugs for rare childhood diseases; its lead clinical candidate, Vincerinone™, is in late-stage clinical development. Prior to founding Edison, Dr. Miller was the founder and Chief Executive Officer of Galileo Laboratories. Dr. Miller holds a PhD in chemistry and an MD, with subspecialty training in critical care medicine. He completed his residency, fellowship and was an assistant professor at Johns Hopkins, and is currently a member of the voluntary faculty at Stanford University Medical Center as anattending physician in medical-surgical critical care.

Event Details
Cost: 
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Event Details: 

Dr. Miller will speak about challenges associated with the discovery and development of drugs for rare pediatric mitochondrial diseases, and applications to adult neurodegenerative diseases.